C
REGN icon

Covestor’s Regeneron Pharmaceuticals REGN Stock Holding History

Covestor’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81K Sell
130
-3
-2% -$2.04K 0.05% 488
2026
Q1 		$103K Sell
133
-141
-51% -$108K 0.07% 281
2025
Q4 		$212K Sell
274
-77
-22% -$52.3K 0.11% 195
2025
Q3 		$198K Buy
351
+14
+4% +$7.92K 0.11% 219
2025
Q2 		$177K Buy
337
+23
+7% +$12.8K 0.1% 238
2025
Q1 		$200K Buy
314
+128
+69% +$88K 0.13% 158
2024
Q4 		$132K Buy
186
+10
+6% +$8.39K 0.08% 354
2024
Q3 		$186K Sell
176
-26
-13% -$28.9K 0.12% 208
2024
Q2 		$212K Hold
202
– – 0.14% 148
2024
Q1 		$195K Buy
202
+14
+7% +$13.3K 0.12% 174
2023
Q4 		$166K Sell
188
-45
-19% -$37.1K 0.11% 216
2023
Q3 		$192K Buy
233
+48
+26% +$37.7K 0.14% 121
2023
Q2 		$133K Sell
185
-80
-30% -$61.7K 0.1% 288
2023
Q1 		$218K Sell
265
-12
-4% -$9.05K 0.19% 83
2022
Q4 		$201K Sell
277
-84
-23% -$62K 0.16% 112
2022
Q3 		$249K Buy
361
+22
+6% +$13.8K 0.22% 55
2022
Q2 		$201K Sell
339
-59
-15% -$38.4K 0.16% 117
2022
Q1 		$279K Buy
398
+173
+77% +$109K 0.19% 73
2021
Q4 		$142K Buy
+225
New +$138K 0.2% 61

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Covestor's REGN Position: Q2 2026 in Review

Covestor reduced its Regeneron Pharmaceuticals (REGN) stake by 2.3% in Q2 2026, selling an estimated $2.04K and leaving 130 shares worth $81K. The position accounts for 0.05% of the portfolio, ranked #488.

Covestor first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $279K in Q1 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Covestor held 130 shares of Regeneron Pharmaceuticals worth $81K as of Q2 2026.
  • Covestor sold 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up 0.05% of Covestor's portfolio in Q2 2026, its #488 holding.
  • Covestor first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Regeneron Pharmaceuticals position peaked at $279K in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.